Ticker >

Makers Laboratories share price

Makers Laboratories Ltd.

BSE: 506919 SECTOR: Pharmaceuticals & Drugs  8598   8   0

155.30
-1.50 (-0.96%)
BSE: 17 Sep 04:01 PM

Price Summary

Today's High

₹ 159.3

Today's Low

₹ 152.8

52 Week High

₹ 176.5

52 Week Low

₹ 101

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationAttractive
The stock is considerably attractive based on intrinsic value.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

91.63 Cr.

Enterprise Value

105.14 Cr.

No. of Shares

0.59 Cr.

P/E

0

P/B

1.82

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  85.13

CASH

0.07 Cr.

DEBT

13.58 Cr.

Promoter Holding

61.27 %

EPS (TTM)

₹  -9.68

Sales Growth

15.38%

ROE

-12.67 %

ROCE

-8.03%

Profit Growth

-9.29 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year15.38%
3 Year3.39%
5 Year1.04%

Profit Growth

1 Year-9.29%
3 Year-232.01%
5 Year-223.21%

ROE%

1 Year-12.67%
3 Year-8.01%
5 Year-5.55%

ROCE %

1 Year-8.03%
3 Year-4.33%
5 Year-2.39%

Debt/Equity

0.264

Price to Cash Flow

-29.92

Interest Cover Ratio

-3.2561

CFO/PAT (5 Yr. Avg.)

0

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2024 61.27 0
Mar 2024 61.27 0
Dec 2023 61.27 0
Sep 2023 61.27 0
Jun 2023 61.27 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has an efficient Cash Conversion Cycle of 24.5998 days.
  • The company has a high promoter holding of 61.27%.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 16.2913740826602.

 Limitations

  • The company has shown a poor profit growth of -232.006765469527% for the Past 3 years.
  • The company has shown a poor revenue growth of 3.39390884055804% for the Past 3 years.
  • Company has a poor ROE of -8.01427634322513% over the past 3 years.
  • Company has a poor ROCE of -4.32507325005988% over the past 3 years
  • Company has low Interest coverage ratio of -3.2561.
  • Company has negative cash flow from operations of -3.0621.
  • The company has a low EBITDA margin of 0.236896469380352% over the past 5 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024
Net Sales 11.54 14.92 11.17 11.45 12.29
Total Expenditure 13.33 15.64 12.29 11.59 12.56
Operating Profit -1.79 -0.72 -1.12 -0.14 -0.27
Other Income 0.19 0.69 0.12 0.15 0.14
Interest 0.35 0.41 0.42 0.46 0.39
Depreciation 0.67 0.68 0.68 0.68 0.72
Exceptional Items 0 0 0 0 0
Profit Before Tax -2.61 -1.11 -2.1 -1.14 -1.24
Tax -0.15 -0.12 -0.15 0.42 -0.02
Profit After Tax -2.46 -0.99 -1.95 -1.56 -1.22
Adjusted EPS (Rs) -4.17 -1.68 -3.3 -2.64 -2.07

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 51.4 44.41 52.38 42.55 49.09
Total Expenditure 48.68 41.1 49.32 46.68 52.85
Operating Profit 2.72 3.31 3.05 -4.13 -3.76
Other Income 0.23 0.41 0.85 1.14 1.15
Interest 0.7 1.6 1.68 1.38 1.63
Depreciation 1.99 4.2 1.91 2.4 2.71
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.25 -2.07 0.31 -6.78 -6.96
Tax 0.37 -0.46 0.14 -0.41 -0.01
Net Profit -0.12 -1.62 0.17 -6.36 -6.95
Adjusted EPS (Rs.) -0.24 -3.15 0.35 -10.78 -11.78

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 4.92 4.92 4.92 5.9 5.9
Total Reserves 39.7 44.7 45.38 52.38 45.55
Borrowings 5.98 5.53 2.69 2.39 6
Other N/C liabilities 3.91 2.9 2.79 3.2 2.96
Current liabilities 19.36 21.07 29.71 20.91 25.73
Total Liabilities 73.87 79.12 85.48 84.79 86.15
Assets
Net Block 32.89 30.59 29.94 40.45 39.88
Capital WIP 0.67 0.12 8.94 0.01 0
Intangible WIP 0.02 0 0 0.03 0
Investments 15.04 23.66 22.55 22.52 22.56
Loans & Advances 1.46 1.5 2.69 2.58 2.83
Other N/C Assets 0.04 0.04 0.01 0.04 0.03
Current Assets 23.77 23.2 21.35 19.16 20.85
Total Assets 73.87 79.12 85.48 84.79 86.15
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 0.25 -2.07 0.31 -6.78 -6.96
Adjustment 2.9 5.47 3.29 3.33 3.64
Changes in Assets & Liabilities 1.11 -1.35 3.75 2.42 0.57
Tax Paid -0.04 -1.38 -0.55 -0.4 -0.32
Operating Cash Flow 4.23 0.67 6.8 -1.42 -3.06
Investing Cash Flow -8.43 -2.65 -8.78 -3.55 -2.04
Financing Cash Flow 2.91 1.37 1.77 4.94 5.12
Net Cash Flow -1.29 -0.61 -0.21 -0.04 0.02

Corporate Actions

Investors Details

PARTICULARS Jun 2023% Sep 2023% Dec 2023% Mar 2024% Jun 2024%
promoters 61.27 61.27 61.27 61.27 61.27
bhawna godha 0.72 0.72 0.72 0.72 0.72
chandurkar investments pr... 1.43 1.43 1.43 1.43 1.43
kaygee investments privat... 17.38 17.38 17.38 17.38 17.38
kaygee laboratories priva... 14.35 14.35 14.35 14.35 14.35
mexin medicaments private... 3.12 3.12 3.12 3.12 3.12
nirmal gigalal jain 1.62 1.62 1.62 1.62 1.62
paschim chemicals pvt ltd... 16.38 16.38 16.38 16.38 16.38
prashant godha 2.08 2.08 2.08 2.08 2.08
premchand godha 2.15 2.15 2.15 2.15 2.15
sameer m chandurkar 0.37 0.37 0.37 0.37 0.37
usha m chandurkar 0.69 0.69 0.69 0.69 0.69
usha premchand godha 0.97 0.97 0.97 0.97 0.97
PARTICULARS Jun 2023% Sep 2023% Dec 2023% Mar 2024% Jun 2024%
investors 38.73 38.73 38.73 38.73 38.73
achyutkumar ratilal modi 1.07 1.07 1.07 1.07 1.07
investor education and pr... - - - - 2.57
llp 0.05 0.02 0.02 0.05 0.03
tanvi jignesh mehta - - - 1.25 1.76
vishal jain - - 0.13 0.13 0.13
investor education and pr... - 2.58 2.58 2.58 -
investor education and pr... 2.45 - - - -

Annual Reports

Ratings & Research Reports

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Company News

Makers Laboratories - Quaterly Results6 Aug 2024, 11:15AM Makers Laboratories - Quaterly Results6 Aug 2024, 11:15AM Makers Laboratories - Quaterly Results6 Aug 2024, 11:15AM Makers Laboratories Informs about press release11 Jul 2024, 2:40PM Makers Laboratories informs about annual report 10 Jul 2024, 12:21PM Makers Laboratories - Quaterly Results23 May 2024, 1:14PM Makers Laboratories - Quaterly Results23 May 2024, 1:14PM Makers Laboratories - Quaterly Results23 May 2024, 1:14PM Makers Laboratories submits financial results 13 Feb 2024, 2:02PM Makers Laboratories - Quaterly Results13 Feb 2024, 12:16PM Makers Laboratories - Quaterly Results13 Feb 2024, 12:16PM Makers Laboratories - Quaterly Results13 Feb 2024, 12:16PM Makers Laboratories informs about compliances-certificate11 Jan 2024, 1:02PM Makers Laboratories informs about loss of share certificate20 Dec 2023, 3:13PM Makers Laboratories informs about loss of share certificate4 Dec 2023, 11:49AM Makers Laboratories - Quaterly Results7 Nov 2023, 12:39PM Makers Laboratories - Quaterly Results7 Nov 2023, 12:39PM Makers Laboratories - Quaterly Results7 Nov 2023, 12:39PM Makers Laboratories informs about disclosure4 Oct 2023, 5:26PM Makers Laboratories informs about outcome of board meeting 14 Aug 2023, 12:27PM Makers Laboratories - Quaterly Results14 Aug 2023, 11:02AM Makers Laboratories informs about loss of share certificate9 Aug 2023, 12:15PM Makers Laboratories informs about loss of share certificate21 Jul 2023, 2:25PM Makers Laboratories - Quaterly Results22 May 2023, 1:33PM Makers Laboratories - Quaterly Results22 May 2023, 1:33PM Makers Laboratories - Quaterly Results22 May 2023, 1:33PM Makers Laboratories informs about compliance certificate12 Apr 2023, 4:50PM Makers Laboratories submits unaudited financial results 13 Feb 2023, 4:16PM Makers Laboratories - Quaterly Results13 Feb 2023, 12:28PM Makers Laboratories - Quaterly Results13 Feb 2023, 12:28PM Makers Laboratories - Quaterly Results13 Feb 2023, 12:28PM Makers Laboratories informs about board meeting 19 Oct 2022, 3:45PM Makers Laboratories informs about loss of share certificates26 Sep 2022, 2:52PM Makers Laboratories informs about newspaper publication16 Aug 2022, 2:42PM Makers Laboratories - Quaterly Results14 Aug 2022, 10:22AM Makers Laboratories - Quaterly Results14 Aug 2022, 10:22AM Makers Laboratories - Quaterly Results14 Aug 2022, 10:22AM Makers Laboratories informs about newspaper publication18 Jul 2022, 10:18AM Makers Laboratories - Quaterly Results27 May 2022, 1:02PM Makers Laboratories informs about board meeting17 May 2022, 4:53PM Makers Laboratories informs about outcome of board meeting6 May 2022, 12:57PM Makers Laboratories informs about compliance certificate24 Mar 2022, 4:45PM Makers Laboratories - Quaterly Results9 Feb 2022, 12:14PM Makers Laboratories - Quaterly Results9 Feb 2022, 12:14PM Makers Laboratories - Quaterly Results9 Feb 2022, 12:14PM Makers Laboratories gets nod to raise Rs 14.75 crore 10 Nov 2021, 4:10PM Makers Laboratories informs about outcome of AGM19 Aug 2021, 3:16PM Makers Laboratories informs about financial results13 Aug 2021, 2:45PM Makers Laboratories informs about unaudited financial results13 Aug 2021, 2:40PM Makers Laboratories informs about board meeting30 Jul 2021, 12:40PM

Makers Laboratories Stock Price Analysis and Quick Research Report. Is Makers Laboratories an attractive stock to invest in?

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Makers Laboratories and its performance over the period of time. Makers Laboratories stock price today is Rs 164.1.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Makers Laboratories cash from the operating activity was Rs -3.0621 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Makers Laboratories has a Debt to Equity ratio of 0.264 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Makers Laboratories , the EPS growth was -9.2908 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Makers Laboratories has OPM of -7.66004257616346 % which is a bad sign for profitability.
     
  • ROE: Makers Laboratories have a poor ROE of -12.6707 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Makers Laboratories is Rs 164.1. One can use valuation calculators of ticker to know if Makers Laboratories share price is undervalued or overvalued.
Last Updated on:
Brief about Makers Laboratories
X